Editorial: Prognostic factors in hepatocellular carcinoma

Editorial: Prognostic factors in hepatocellular carcinoma

Bibliographic Details
Main Authors:	Liliana Chemello, Pradeep Kumar Shukla, Marcello Dallio
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-11-01
Series:	Frontiers in Medicine
Subjects:	HCC tumor prognosis hepatocellular carcinoma immunotherapy biomarkers
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2023.1331207/full

Similar Items

Editorial: Identification and characterization of molecular targets in hepatocellular carcinoma
by: Vinay Kumar, et al.
Published: (2023-06-01)

Integrated Proteomics and Bioinformatics to Identify Potential Prognostic Biomarkers in Hepatocellular Carcinoma
by: Zhang Q, et al.
Published: (2021-03-01)

Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma
by: Xiaoyi Hu, et al.
Published: (2020-09-01)

Preoperative Serum Glycan Levels Reflect Progression of Patients With Hepatocellular Carcinoma
by: Sheng‐Sheng Liu, et al.
Published: (2024-10-01)

Corrigendum: Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma
by: Xiaoyi Hu, et al.
Published: (2020-11-01)

Cellular senescence-related genes: predicting prognosis in hepatocellular carcinoma
by: Weiwei Yuan, et al.
Published: (2023-10-01)

Diagnostic and prognostic value of m5C regulatory genes in hepatocellular carcinoma
by: Xiawei Yang, et al.
Published: (2022-08-01)

Cytochrome P450 family members are associated with fast-growing hepatocellular carcinoma and patient survival: An integrated analysis of gene expression profiles
by: Zhao-Zhen Liu, et al.
Published: (2019-01-01)

Circulating Tumor Cells for Predicting the Prognostic of Patients with Hepatocellular Carcinoma: A Meta Analysis
by: Jun-Li Fan, et al.
Published: (2015-09-01)

Comprehensive Analysis of HHLA2 as a Prognostic Biomarker and Its Association With Immune Infiltrates in Hepatocellular Carcinoma
by: Lin Ding, et al.
Published: (2022-03-01)

Constructing an immune-related prognostic signature for predicting prognosis and immune response in hepatocellular carcinoma
by: Lichao Cao, et al.
Published: (2024-07-01)

Transcription Factors and Methylation Drive Prognostic miRNA Dysregulation in Hepatocellular Carcinoma
by: Shijie Qin, et al.
Published: (2021-07-01)

Bibliometric study of immunotherapy for hepatocellular carcinoma
by: Zhiyi Li, et al.
Published: (2023-08-01)

Custom gene expression panel for evaluation of potential molecular markers in hepatocellular carcinoma
by: Srinivas Reddy Pallerla, et al.
Published: (2022-11-01)

Prognostic Value of Cancer-Associated Fibroblast-Related Gene Signatures in Hepatocellular Carcinoma
by: Wenge Dong, et al.
Published: (2022-06-01)

Structural insights into antibody-based immunotherapy for hepatocellular carcinoma
by: Masaud Shah, et al.
Published: (2025-01-01)

Immunological significance of prognostic alternative splicing signature in hepatocellular carcinoma
by: Qianhui Xu, et al.
Published: (2021-04-01)

Mutational and transcriptional alterations and clinicopathological factors predict the prognosis of stage I hepatocellular carcinoma
by: Zhiqiang Li, et al.
Published: (2022-09-01)

Construction and Validation of an Epigenetic Regulator Signature as A Novel Biomarker For Prognosis, Immunotherapy, And Chemotherapy In Hepatocellular Carcinoma
by: Jialiang Cai, et al.
Published: (2022-07-01)

MicroRNAs as Diagnostic Tools in Hepatocellular Carcinoma
by: Jessica Evangelista, et al.
Published: (2021-11-01)

Apolipoprotein E: A Potential Prognostic and Diagnostic Biomarker for Hepatocellular Carcinoma
by: Li Y, et al.
Published: (2025-02-01)

Circulating Tumor Cells as a Promising Tool for Early Detection of Hepatocellular Carcinoma
by: Mahsa Salehi, et al.
Published: (2023-09-01)

Liver Regeneration-Related Genes of Nontumor Liver Tissues Predict the Prognosis of Patients with Hepatocellular Carcinoma
by: Xu Y, et al.
Published: (2023-12-01)

NIFK, an independent prognostic biomarker of hepatocellular carcinoma, is correlated with immune infiltration
by: Fei Cheng, et al.
Published: (2023-05-01)

Cell Pair Algorithm-Based Immune Infiltrating Cell Signature for Improving Outcomes and Treatment Responses in Patients with Hepatocellular Carcinoma
by: Xiao Zhang, et al.
Published: (2023-01-01)

Biomarkers predicting the efficacy of immune checkpoint inhibitors in hepatocellular carcinoma
by: Ran Qin, et al.
Published: (2023-12-01)

MUTYH is a potential prognostic biomarker and correlates with immune infiltrates in hepatocellular carcinoma
by: Fan Yang, et al.
Published: (2022-12-01)

Circular RNAs Sparkle in the Diagnosis and Theranostics of Hepatocellular Carcinoma
by: Menglan Wang, et al.
Published: (2021-02-01)

Nuf2 Is a Prognostic-Related Biomarker and Correlated With Immune Infiltrates in Hepatocellular Carcinoma
by: Xingwei Xie, et al.
Published: (2021-03-01)

Disulfidptosis-related signatures for prognostic and immunotherapy reactivity evaluation in hepatocellular carcinoma
by: Jiajing Zhao, et al.
Published: (2023-12-01)

Evaluation of tumor mutational burden in small early hepatocellular carcinoma and progressed hepatocellular carcinoma
by: Mary Wong, et al.
Published: (2021-12-01)

Construction and validation of a survival prognostic model for stage III hepatocellular carcinoma: a real-world, multicenter clinical study
by: Shuai Hao, et al.
Published: (2023-06-01)

Neoadjuvant Therapy for Hepatocellular Carcinoma
by: Yin Z, et al.
Published: (2022-08-01)

CLEC3B as a Potential Prognostic Biomarker in Hepatocellular Carcinoma
by: Xing-Wei Xie, et al.
Published: (2021-01-01)

A novel prognostic prediction model of cuprotosis-related genes signature in hepatocellular carcinoma
by: Ruo-Nan Shao, et al.
Published: (2023-08-01)

Hepatocellular Carcinoma. Part 2: Clinical Presentation and Diagnosis
by: Lior Charach, et al.
Published: (2017-06-01)

In Situ Vaccination as a Strategy to Modulate the Immune Microenvironment of Hepatocellular Carcinoma
by: Isabella Lurje, et al.
Published: (2021-05-01)

Multi-omics analysis and validation of the tumor microenvironment of hepatocellular carcinoma under RNA modification patterns
by: Yuanqian Yao, et al.
Published: (2023-09-01)

Red Cell Distribution Width as a Predictor of Survival in Patients with Hepatocellular Carcinoma
by: Gianpaolo Vidili, et al.
Published: (2024-02-01)

Portal hypertension in patients with hepatocellular carcinoma and immunotherapy: prognostic relevance of CT-morphologic estimates
by: Lukas Müller, et al.
Published: (2023-04-01)